Lonza Group AG
LONN
Rankning i aktier
#447
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Aktiekurs
$766.95
Marknadsvärde
$53.57B
Förändring (1 dag)
1.35%
Förändring (1 år)
9.01%
Land
CH
Handel Lonza Group AG (LONN)
Kategori
Healthcare
Utdelningsavkastning för Lonza Group AG (LONN)
Utdelningsavkastningen (TTM) för Lonza Group AG (aktiesymbol: LONN) per 2026 är: 0
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.71%
Genomsnittlig utdelningsavkastning de senaste 5 åren: 0.71%
Historik för utdelningsavkastning för Lonza Group AG (LONN) från 2004 till 2026
Utdelningsavkastning i slutet av varje år (TTM)
| År | Utdelningsavkastning | Ändra |
|---|---|---|
| 2025 | 0.74% | -1.33% |
| 2024 | 0.75% | -25.00% |
| 2023 | 1.00% | 51.52% |
| 2022 | 0.66% | 65.00% |
| 2021 | 0.40% | -16.67% |
| 2020 | 0.48% | -38.46% |
| 2019 | 0.78% | -27.78% |
| 2018 | 1.08% | 20.00% |
| 2017 | 0.90% | -40.79% |
| 2016 | 1.52% | -7.88% |
| 2015 | 1.65% | -19.90% |
| 2014 | 2.06% | -24.82% |
| 2013 | 2.74% | -35.22% |
| 2012 | 4.23% | 9.30% |
| 2011 | 3.87% | 65.38% |
| 2010 | 2.34% | -0.43% |
| 2009 | 2.35% | 45.96% |
| 2008 | 1.61% | 62.63% |
| 2007 | 0.99% | -6.60% |
| 2006 | 1.06% | -34.97% |
| 2005 | 1.63% | -20.10% |
| 2004 | 2.04% | 0.00% |
Utdelningsavkastning (TTM) för liknande företag eller konkurrenter
| Företag | Utdelningsavkastning | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.07% |
AU
|
|
| 0.00% |
NL
|
|
| 0.72% |
BE
|
